Under the regulations, puberty blockers are defined as ‘gonadotropin-releasing hormone analogues’, which are medicines consisting of buserelin, gonadorelin, goserelin, leuprorelin acetate, naferelin ...
The ban currently applies to gonadotropin-releasing hormone analogues - medicines that consist of, or contain, buserelin, gonadorelin, goserelin, leuprorelin acetate, nafarelin or triptorelin.